Further scientific data reported by Schotte et al. confirmed that these three miRNAs can be upregulated (14-25-fold) in childhood ALL patients with TEL-AML1 fusion (in 12 of 31 and 12 of 29 samples) and that their overexpression confers vincristine and daunorubicin resistance [72]. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.